Left Ventricular Capture Management (LVCM) Software Download Clinical Trial

This study has been completed.
Sponsor:
Information provided by:
Medtronic Cardiac Rhythm Disease Management
ClinicalTrials.gov Identifier:
NCT00268281
First received: December 21, 2005
Last updated: October 11, 2006
Last verified: October 2006

December 21, 2005
October 11, 2006
December 2004
Not Provided
To evaluate the accuracy of left ventricular capture management (LVCM)
Same as current
Complete list of historical versions of study NCT00268281 on ClinicalTrials.gov Archive Site
  • To compare left ventricular capture management (LVCM) measurements to a similar measurement taken automatically when subjects are completing normal daily activities
  • To evaluate subject rhythm and rate immediately following an LVCM measurements
  • To characterize all adverse events
Same as current
Not Provided
Not Provided
 
Left Ventricular Capture Management (LVCM) Software Download Clinical Trial
Left Ventricular Capture Management (LVCM) Software Download Clinical Trial

Heart failure is a progressive disease that decreases the pumping action of the heart. This may cause a backup of fluid in the heart and may result in heart beat changes. When there are changes in the heart beat sometimes an implantable heart device is used to control the rate and rhythm of the heart beat. In certain heart failure cases, when the two lower chambers of the heart no longer beat in a coordinated manner, cardiac resynchronization therapy (CRT) may be prescribed.

Left Ventricular Capture Management (LVCM) refers to the overall method for determining left ventricular thresholds (level of energy needed to effectively pace the tissue in the lower left chamber of the heart) by measuring, analyzing, and adjusting energy delivered from the CRT device to the pacing lead.

The purpose of the Left Ventricular Capture Management Software Download Clinical Trial was to evaluate the accuracy of the Left Ventricular Capture Management (LVCM) feature to support LVCM feature approval in future cardiac resynchronization therapy with defibrillation (CRT-D) devices

Not Provided
Interventional
Not Provided
Allocation: Non-Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Heart Failure
Device: Left Ventricular Capture Management Software
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
107
July 2005
Not Provided

Inclusion Criteria:

  • Subjects who successfully underwent implantation of an InSync II Marquis system

Exclusion Criteria:

  • Subjects who are post-heart transplant
  • Subjects enrolled in a concurrent study that may confound the results of this study
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00268281
238
Not Provided
Not Provided
Medtronic Cardiac Rhythm Disease Management
Not Provided
Not Provided
Medtronic Cardiac Rhythm Disease Management
October 2006

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP